BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 1458006)

  • 1. Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency.
    Longo KA; Berryman DE; Kelder B; Charoenthongtrakul S; Distefano PS; Geddes BJ; Kopchick JJ
    Growth Horm IGF Res; 2010 Feb; 20(1):73-9. PubMed ID: 19747867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.
    Veldhuis JD; Evans WS; Bowers CY; Anderson S
    Endocrine; 2001 Feb; 14(1):45-62. PubMed ID: 11322501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
    Amselem S; Sobrier ML; Duquesnoy P; Rappaport R; Postel-Vinay MC; Gourmelen M; Dallapiccola B; Goossens M
    J Clin Invest; 1991 Mar; 87(3):1098-102. PubMed ID: 1999489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth hormone receptor and dwarfism].
    Postel-Vinay MC
    Rev Prat; 1994 May; 44(10):1281-5. PubMed ID: 7939185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical characteristics of growth hormone receptor deficiency (Laron syndrome).
    Rosenbloom AL; Savage MO; Blum WF; Guevara-Aguirre J; Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():121-4. PubMed ID: 1458006
    [No Abstract]   [Full Text] [Related]  

  • 6. The chronicle of growth hormone receptor deficiency (Laron syndrome).
    Rosenbloom AL
    Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
    Carel JC; Chaussain JL; Chatelain P; Savage MO
    Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations in the growth hormone receptor gene of patients with Laron syndrome.
    Amselem S; Duriez B; Sobrier ML; Duquesnoy P; Goossens M
    Acta Paediatr Suppl; 1992 Sep; 383():132-3. PubMed ID: 1458008
    [No Abstract]   [Full Text] [Related]  

  • 9. For debate: did the small-bodied hominis from flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)?
    Laron Z; Kornreich L; Hershkovitz I
    Pediatr Endocrinol Rev; 2006 Jun; 3(4):345-6. PubMed ID: 16816802
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.